Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» The FDA is keeping its partial hold on Repros’ Proellex
The FDA is keeping its partial hold on Repros’ Proellex
The FDA is keeping its partial hold on Repros’ Proellex
Submitted by
admin
on April 10, 2017 - 10:14pm
Source:
Endpoints
News Tags:
FDA
Proellex
Repros Therapeutics
Headline:
The FDA is keeping its partial hold on Repros’ Proellex
Do Not Allow Advertisers to Use My Personal information
